Author contributions
B.K.P., K.K., T.P.A. and M.R.-L. conceived the study. M.P.P.L., G.E.L. and M.R.-L. wrote the first draft. M.R.-L. is the principal investigator. M.R.-L., M.P.P.L. and G.E.L. had full access to the data in the study, verified the data, and had full responsibility for the decision to submit and publish. M.P.P.L., G.E.L., M.R.-L., T.P.A., K.K., B.K.P., T.P.J.S., R.C., G.V.H. and J.J.H. contributed to protocol development and study design. G.E.L., M.P.P.L., S.L.B., C.S.F., N.S.N., B.L., U.N., M.Ø., K.T. and B.T. performed the experiments and collected the data. T.P.A. and K.T. performed pharmacological management. B.H., J.J.H. and G.V.H. performed biochemical analyses of incretins or stable isotopes. J.C.B. performed the accelerometer analyses. M.R.-L., K.T., N.S.N., G.E.L. and M.P.P.L. integrated and quality-checked the data. M.R.-L. and C.G.D. performed the statistical analyses. G.E.L., M.P.P.L., R.C. and M.R.-L. wrote the SAP. All authors read the SAP, critically revised it for important intellectual content and approved the final version. All authors read the manuscript, critically revised it for important intellectual content and approved the final version.